The IL-1 receptor antagonist anakinra (kineret®) stabilizes the NLRP3 mutation-specific risk for hearing loss in patients with severe cryopyrin-associated periodic syndromes (CAPS) [PDF]
Bengt Hallén +2 more
core +2 more sources
Biological Therapies for Urate Lowering and Inflammation Control in Gout Management. [PDF]
Zhou Y +5 more
europepmc +1 more source
Severe Gout During Arsenic Therapy: Insights on Oxidative Stress and Interleukin-1β in Gout. [PDF]
Hamilton J, Alexander A.
europepmc +1 more source
Pathogenic TET2 Variants and Autoinflammatory Manifestations in Myeloid Hematologic Malignancies: Case Report and Literature Review. [PDF]
Porto Fuentes Ó +2 more
europepmc +1 more source
Tolerability and effect of inhibiting microfibrillar-associated protein 4 in small intestinal anastomotic healing. [PDF]
Andresen RR +18 more
europepmc +1 more source
Anakinra-Dependent Recurrent Pericarditis: The Role of the R202Q Variant of the MEFV Gene [PDF]
Alessandro Andreis +4 more
openalex +1 more source
Disproportionality Analysis of Adverse Events Associated with IL-1 Inhibitors in the FDA Adverse Event Reporting System (FAERS). [PDF]
Lei J +7 more
europepmc +1 more source
An immunoregenerative approach to mitigate post-traumatic osteoarthritis after intra-articular fracture. [PDF]
Valerio MS +6 more
europepmc +1 more source

